Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

FHS
July 13, 2023
1:13 pm

Evotec SE today announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.

FDA issues guidance on using real-world data for drug development – Pharmaceutical Technology

Under Section 505 of the Cures Act, the FDA was mandated to create a framework on how real-world evidence and data could be used in

August 31, 2023

CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board – Biotech Investments

Issuer: CureVac / Key word(s): Personnel 20.06.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Appoints International Financial

June 21, 2023

How diet, exercise can improve mental and physical functioning in older cancer survivors

Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Dana Farber Cancer Institute in Boston have been awarded

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.